Though biosimilar competition in Europe increased, allowing insulin prices to be low, branded drugs have always been the order of the day
At 40mg, users gain a strategic advantage: longer dosing intervals, greater protocol flexibility, and reduced frequency of vial preparation
8,39 In practice, however, basal insulin is usually considered as a later therapy option for patients with T2D inadequately controlled on other therapies (Figure 1)
By activating the metabolism, energy production from stored fat reserves is promoted, thus reducing stubborn fat deposits especially in problem areas such as the stomach, hips, and thighs
The area postrema is the key non-overlapping target retatrutide does not appreciably engage it